Global Fund, World Bank provide Malawi with $48.5 million to expand HIV/AIDS services, commission says

NewsGuard 100/100 Score

Malawi's National AIDS Commission in a statement issued Thursday announced that it has received $48.5 million from the Global Fund To Fight AIDS, Tuberculosis and Malaria and the World Bank to expand HIV/AIDS services in the country up to December, Xinhua News Agency reports.

According to NAC, the Global Fund allocated $44.3 million, while the World Bank provided the remaining $4.2 million.

NAC said that $12.5 million has been transferred to UNICEF for the procurement of health products, including antiretroviral drugs and that $31.8 million will be used to strengthen health systems.

According to Xinhua News Agency, the country, with support from the Global Fund, has provided no-cost antiretrovirals to more than 100,000 HIV-positive people since 2005 (Xinhua News Agency, 11/1).

Biziwick Mwale, chief of NAC, in July said the country aims to expand the number of people with no-cost drug access to 150,000 by the end of December.

He added that the biggest challenge to increasing access to antiretrovirals is the shortage of health care workers in the country.

A recent survey by the Ministry of Health indicates that the country, which has a population of 12 million, employs 150 doctors.

According to UNAIDS estimates, there are about 930,000 people living with HIV/AIDS in Malawi, and approximately 78,000 AIDS-related deaths occur each year.

The country's HIV prevalence is about 14% (Kaiser Daily HIV/AIDS Report, 7/10).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations